SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-042925
Filing Date
2024-05-14
Accepted
2024-05-14 16:06:15
Documents
96
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205725-10q_immucell.htm   iXBRL 10-Q 1043859
2 CERTIFICATION ea020572501ex31_immucell.htm EX-31 9418
3 CERTIFICATION ea020572501ex32_immucell.htm EX-32 4521
9 GRAPHIC image_001.jpg GRAPHIC 79497
10 GRAPHIC image_002.jpg GRAPHIC 77516
  Complete submission text file 0001213900-24-042925.txt   7359833

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE iccc-20240331.xsd EX-101.SCH 67249
5 XBRL CALCULATION FILE iccc-20240331_cal.xml EX-101.CAL 42465
6 XBRL DEFINITION FILE iccc-20240331_def.xml EX-101.DEF 326363
7 XBRL LABEL FILE iccc-20240331_lab.xml EX-101.LAB 589777
8 XBRL PRESENTATION FILE iccc-20240331_pre.xml EX-101.PRE 329421
100 EXTRACTED XBRL INSTANCE DOCUMENT ea0205725-10q_immucell_htm.xml XML 921968
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 24944262
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)